Establishment of a method for evaluating intracellular antibiotic efficacy in Brucella abortus-infected Mono Mac 6 monocytes

Journal of Antimicrobial Chemotherapy

Volumn 61, Issue 1, 2008, Pages 128-134

  Valderas, Michelle Wright ^a   Barrow, William W ^a  

^a OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

Antibiotic; Brucella; Drug screening; Macrophage

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; DOXYCYCLINE; GENTAMICIN; RIFAMPICIN; STREPTOMYCIN SULFATE; TETRACYCLINE;

ANIMAL CELL; ANTIMICROBIAL ACTIVITY; ARTICLE; BRUCELLA ABORTUS; BRUCELLOSIS; CELL FUNCTION; CELL LINE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SCREENING; HUMAN; HUMAN CELL; IN VITRO STUDY; MACROPHAGE; MINIMUM INHIBITORY CONCENTRATION; MONOCYTE; MOUSE; NONHUMAN; PHENOTYPE;

ANIMALS; ANTI-BACTERIAL AGENTS; BRUCELLA ABORTUS; CELL LINE, TUMOR; CELL SURVIVAL; HUMANS; MACROPHAGES; MICE; MICROBIAL SENSITIVITY TESTS; MONOCYTES;

EID: 37549057605     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkm433     Document Type: Article

References (37)

1. Acha PN, Szyfres B. Zoonoses and Communicable Diseases Common to Man and Animals, 2nd edn. Washington, DC: Pan American Health Organization, 1987; 24-45.
2. Nicoletti P. A short history of brucellosis. Vet Microbiol 2002; 90: 5-9.
3. Acocella G, Bertrand A, Beytout J et al. Comparison of three different regimens in the treatment of acute brucellosis: A multicenter multinational study. J Antimicrob Chemother 1989; 23: 433-9.
4. Young E. Brucella species. In: Mandel G, Bennett J, Dolin R, eds. Principles and Practice of Infectious Disease. Philadelphia, PA: Churchill-Livingstone, 2000; 2386-92.
5. World Health Organization. Brucellosis in humans and animals: WHO guidance. Geneva: Department of Communicable Disease Surveillance and Response, World Health Organization, 2004.
6. Franz DR, Jahrling PB, McClain DJ et al. Clinical recognition and management of patients exposed to biological warfare agents. Clin Lab Med 2001; 21: 435-73.
7. Joint FAO/WHO Expert Commitee on Brucellosis (Sixth Report). Geneva: World Health Organization, 1986.
8. McLean DR, Russell N, Khan MY. Neurobrucellosis: Clinical and therapeutic features. Clin Infect Dis 1992; 15: 582-90.
9. Hall W. Modem chemotherapy for brucellosis in humans. Rev Infect Dis 1990; 12: 1060-99.
10. Memish Z, Mah MW, Al Mahmoud S et al. Brucella bacteraemia: clinical and laboratory observations in 160 patients. J Infect 2000; 40: 59-63.
11. Valderas MW, Roop RM, 2nd. Brucella and bioterrorism. In: Anderson B, Friedman H, Bendinelli M, eds. Microorganisms and Bioterrorism. New York, NY: Springer, 2006; 139-53.
12. Barrow EW, Bourne PC, Clinkenbeard KD et al. MIC and FIC evaluations of select agents using high-throughput screening. In: Abstracts of the ASM Biodefense and Emerging Diseases Research Meeting, Washington, DC, 2007. Abstract D-072.
13. Ziegler-Heitbrock HW, Thiel E, Futterer A et al. Establishment of a human cell line (Mono Mac 6) with characteristics of mature monocytes. Int J Cancer 1988; 41: 456-61.
14. Neumeister B. Intracellular multiplication of Legionella species and the influence of amoebae on their intracellular growth in human monocytes: Mono Mac 6 cells and Acanthamoeba castellanii as suitable in vitro models. Methods Mol Biol 2004; 268: 141-51.
15. Neumeister B, Schoniger S, Faigle M et al. Multiplication of different Legionella species in Mono Mac 6 cells and in Acanthamoeba castellanii. Appl Environ Microbiol 1997; 63: 1219-24.
16. Wright EL, Quenelle DC, Suling WJ et al. Use of Mono Mac 6 human monocytic cell line and J774 murine macrophage cell line in parallel antimycobacterial drug studies. Antimicrob Agents Chemother 1996; 40: 2206-8.
17. Sato K, Ogasawara K, Akaki T et al. MICs and MBCs of levofloxacin, clarithromycin, and KRM-1648 for Mycobacterium tuberculosis and M. avium complex residing in MONO-MAC-6 human macrophage-like cell and A-549 human type II alveolar epithelial cell lines, Kekkaku 1999; 74: 571-7.
18. Suling WJ, Seitz LE, Pathak V et al. Antimycobacterial activities of 2,4-diamino-5-deazapteridine derivatives and effects on mycobacterial dihydrofolate reductase. Antimicrob Agents Chemother 2000; 44 2784-93.
19. Tomioka H, Sato K, Kajitani H et al. Comparative antimicrobial activities of the newly synthesized quinolone WQ-3034, levofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex. Antimicrob Agents Chemother 2000; 44: 283-6.
20. Tomioka H, Sato K, Sano C et al. Intramacrophage passage of Mycobacterium tuberculosis and M. avium complex alters the drug susceptibilities of the organisms as determined by intracellular susceptibility testing using macrophages and type II alveolar epithelial cells. Antimicrob Agents Chemother 2002; 46: 519-21.
21. Arenas GN, Staskevich AS, Aballay A et al. Intracellular trafficking of Brucella abortus in J774 macrophages. Infect Immun 2000; 68: 4255-63.
22. Alton GG, Jones LM, Angus RD et al. Techniques for the Brucellosis Laboratory. Paris, France: Institut National de la Recherche Agronomique, 1988.
23. Pick E. Microassays for superoxide and hydrogen peroxide production and nitroblue tetrazolium reduction using an enzyme immunoassay microplate reader. Methods Enzymol 1986; 132: 407-21.
24. Tonks A, Morris RH, Price AJ et al. Dipalmitoylphosphatidylcholine modulates inflammatory functions of monocytic cells independently of mitogen activated protein kinases. Clin Exp Immunol 2001; 124 86-94.
25. Tosk J, Lau BH, Lui P et al. Chemiluminescence in a macrophage cell line modulated by biological response modifiers. J Leukoc Biol 1989; 46: 103-8.
26. Valderas MW. Molecular Characterization of a Second Superoxide Dismutase Gene (sodM) of Staphylococcus aureus and Effects of SodM and SodA on Oxidative Stress Resistance and Virulence. PhD Dissertation. Fort Worth, TX: University of North Texas Health Science Center at Fort Worth, 2001.
27. Sun YH, Rolan HG, den Hartigh AB et al. Brucella abortus virB12 is expressed during infection but is not an essential component of the type IV secretion system. Infect Immun 2005; 73: 6048-54.
28. Baykam N, Esener H, Ergonul O et al. In vitro antimicrobial susceptibility of Brucella species. Int J Antimicrob Agents 2004; 23: 405-7.
29. Garcia-Rodriguez JA, Garcia Sanchez JE, Trujillano I. Lack of effective bactericidal activity of new quinolones against Brucella spp. Antimicrob Agents Chemother 1991; 35: 756-9.
30. Lopez-Merino A, Contreras-Rodriguez A, Migranas-Ortiz R et al. Susceptibility of Mexican Brucella isolates to moxifloxacin, ciprofloxacin and other antimicrobials used in the treatment of human brucellosis. Scand J Infect Dis 2004; 36: 636-8.
31. Seral C, Barcia-Macay M, Mingeot-Leclercq MP et al. Comparative activity of quinolones (ciprofloxacin, levofloxacin, moxifloxacin and garenoxacin) against extracellular and intracellular infection by Listeria monocytogenes and Staphylococcus aureus in J774 macrophages. J Antimicrob Chemother 2005; 55: 511-7.
32. Arkel YS, Ku DH, Thurston AL. The effect of thalidomide on tissue factor activity in Mono Mac 6 cells and the relationship to tumor necrosis factor (TNF)-α-stimulated cells. J Thromb Haemost 2003; 1: 2691-2.
33. Barrow EW, Westbrook L, Bansal N et al. Antimycobacterial activity of 2-methyl-adenosine. J Antimicrob Chemother 2003; 52: 801-8.
34. Johannessen LN, Nilsen AM, Lovik M. The mycotoxins citrinin and gliotoxin differentially affect production of the pro-inflammatory cytokines tumour necrosis factor-α and interleukin-6, and the anti-inflammatory cytokine interleukin-10. Clin Exp Allergy 2005; 35: 782-9.
35. Jonas D, Engels I, Daschner FD et al. The effect of azithromycin on intracellular Legionella pneumophila in the Mono Mac 6 cell line at serum concentrations attainable in vivo. J Antimicrob Chemother 2000; 46: 385-90.
36. Jonas D, Engels I, Friedhoff C et al. Efficacy of moxifloxacin, trovafloxacin, clinafloxacin and levofloxacin against intracellular Legionella pneumophila. J Antimicrob Chemother 2001; 47: 147-52.
37. Neumeister B, Kleihauer A, Rossmann V et al. Induction of cytokines and expression of surface receptors in Mono Mac 6 cells after infection with different Legionella species. APMIS 1998; 106: 319-33.